Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,2412,260 of 20,252 grants

Active NON-SBIR/STTR RPGS
Pathways of Injury and Repair in Barrett's Carcinogenesis
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROGRAM SUMMARY The central hypothesis of this program project is that “Altered squamous epithelial integrity (Prj 1) and inflammatory injury (Prj 2) activate signaling pathways in...

$22.69M
USD
Active NON-SBIR/STTR RPGS
Deciphering the Molecular Genetics of VSIG10L in Barrett's Neoplasia
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The etiology of Barrett's esophagus (BE), a molecularly complex disorder of the distal esophagus, remains elusive. Patients with BE are at an increase...

Active NON-SBIR/STTR RPGS
Inflammation And Submucosal Glands During Esophageal Injury And Repair
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The etiology of Barrett's esophagus (BE), a complex metaplastic disorder of the distal esophagus, remains elusive. Patients with BE are at an increased risk of...

Active NON-SBIR/STTR RPGS
EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The etiology of Barrett's esophagus (BE), a molecularly complex disorder of the distal esophagus, remains elusive. Patients with BE are at an increase...

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The Administrative Core provides strong, centralized scientific and administrative leadership to the PPG, which facilitates synergistic interactions between the fou...

Active NON-SBIR/STTR RPGS
Bioreagents & Resources Core
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The Biospecimen and Reagents Core [BRC] provides high quality annotated specimens and expert pathology consultation to enhance the P01 projects. The BR&C CWRU a...

Active NON-SBIR/STTR RPGS
Core B: Translational, Cellular and Molecular Analysis
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – CELLULAR IMAGING AND GENOMICS CORE B Core B, the Cellular Genomics and Imaging Core (CGI), will provide centralized experimental processing services and primary data ana...

Active NON-SBIR/STTR RPGS
Core C: Biostatistics
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – BIOSTATISTICS CORE C The goal of the Biostatistics Core is to provide support for the statistical analysis generated from three projects. These supportive functions incl...

Completed NON-SBIR/STTR RPGS
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

ABSTRACT The SETER/PR index of sensitivity to endocrine therapy measures endocrine receptor-related transcription from formalin-fixed paraffin-embedded tumor sections and is highly...

$3.7M
USD
Active NON-SBIR/STTR RPGS
Probing the role of somatic X-chromosome alterations in shaping cancer sex differences
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY Cancer is a major global public health problem and the second leading cause of death in the United States. Many cancer types display differences in incidence betwee...

$5.47M
USD
Completed OTHER RESEARCH-RELATED
Role of BCL11B in lineage ambiguous leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2025

PROJECT SUMMARY Acute leukemias of ambiguous lineage (ALAL) are high-risk leukemia subtypes and include mixed phenotype acute leukemia (MPAL) and early T cell precursor acute lymph...

$1.36M
USD
Active NON-SBIR/STTR RPGS
Mental Health CPR: Transforming Cancer Survivors' Mental Health with Community Participatory Reach for Equity
NATIONAL CANCER INSTITUTE Ponce School of Medicine United States 2023 – 2028

PROJECT SUMMARY Hispanic cancer patients and survivors face social and structural inequalities perpetuating mental health disparities. Despite these challenges, the study team and...

$13.77M
USD
Active NON-SBIR/STTR RPGS
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer care
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

Personalized cancer treatment is becoming a reality. The real-world adoption of broad genomic profiling (BGP) has enabled the simultaneous testing of hundreds of potentially target...

$7.07M
USD
Active NON-SBIR/STTR RPGS
Functions of mutant IDH in cholangiocarcinoma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

PROJECT SUMMARY Isocitrate dehydrogenase 1 is the most frequently mutated metabolic gene across all cancers. Among epithelial malignancies, IDH1 mutations are particularly common i...

$6.54M
USD
Active NON-SBIR/STTR RPGS
preclinical optimization of BCMA directed T cell therapy
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2023 – 2028

PROJECT SUMMARY The pillars of multiple myeloma (MM) therapy are DNA alkylators (cyclophosphamide, melphalan), proteasome inhibitors (bortezomib, carfilzomib, ixazomib), glucocorti...

$6.22M
USD
Active OTHER RESEARCH-RELATED
K12 Training for Clinical and Translational Oncology Researchers
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2023 – 2028

Abstract: A critical requirement to sustain the rapid advances in clinical oncology research that have been made over the last 20-years is to train and mentor the next generation o...

$5.9M
USD
Active NON-SBIR/STTR RPGS
Development of blood-based methylation biomarkers for CRC risk prediction
NATIONAL CANCER INSTITUTE Temple University of the Commonwealth United States 2023 – 2028

Development of blood-based methylation biomarkers for CRC risk prediction Colorectal cancer (CRC) incidence and mortality rates are disproportionately higher in African Americans (...

$5.26M
USD
Active NON-SBIR/STTR RPGS
Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT (DESCRIPTION) Since the early 1980s, American Indians and Alaska Natives (AIANs) have maintained the highest rates of commercial cigarette smoking of any r...

$7.44M
USD
Completed SBIR-STTR RPGS
An integrated microfluidic device for patient-derived micro-organospheres
NATIONAL CANCER INSTITUTE Xilis, Inc United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Functional precision oncology holds great potential to improve the current clinical paradigm by using patient- derived ex vivo systems (e.g., PDXs and orga...

$4M
USD
Active NON-SBIR/STTR RPGS
Unlocking the Economics of Cancer Control in Uganda Using KeyScope
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2027

PROJECT SUMMARY / ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as “NOT-CA-23-052. Surgery is the foundation of cance...

$1.5M
USD